Moderna MRNA announced that it has dosed the first U.S. patient in a phase I study evaluating mRNA-4200, an investigational ...

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S.

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...

Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Malignant melanoma (cancer of the skin or mucous membranes), developed at the expense of ...

CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...

The battle against the most dangerous type of skin cancer has made a huge leap forward, and it could dramatically change the way aggressive cancers are treated. In early June 2026, significant ...

Add Yahoo as a preferred source to see more of our stories on Google. (NewsNation) — Most Americans became familiar with mRNA technology during the COVID-19 pandemic, but researchers say the same ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research reveals that a crucial T-cell population can be reprogrammed in animal models by ...

Fact check - The narrative mixes a number of scientific terms related to vaccines and then draws a false conclusion.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. discusses the findings of the Centers for ...